Riluzole 50 mg in 10 mL Oral Suspension
RxNorm 2058147
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2058147 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: riluzole 50 mg in 10 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Riluzole 5 mg/ML Oral Suspension
(Atom ID: 12326594)
SYPrescribable
Synonym (SY):
Riluzole 25 mg per 5 mL Oral Suspension
(Atom ID: 10782981)
PSNPrescribable
Prescribable Name (PSN):
Riluzole 50 mg in 10 mL Oral Suspension
(Atom ID: 10336850)
SYPrescribable
Synonym (SY):
Riluzole 50 mg per 10 mL Oral Suspension
(Atom ID: 10336851)
Patient Education
Riluzole
Riluzole is used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease). Riluzole is in a class of medications called benzothiazoles. It works by changing the activity of certain natural substances in the body that affect nerves and muscles.
[Learn More]
* Please review the disclaimer below.